Cargando…
Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment
Exaggerated release of arginine vasopressin (AVP) is profoundly involved in impaired water excretion and related hyponatremia. Such disorders underlie syndromes of inappropriate secretion of antidiuretic hormone (SIADH) and edematous diseases, such as congestive heart failure and decompensated liver...
Autor principal: | Ishikawa, San-e |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704119/ https://www.ncbi.nlm.nih.gov/pubmed/29088071 http://dx.doi.org/10.3390/jcm6110102 |
Ejemplares similares
-
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016) -
Genes Related to Oxytocin and Arginine-Vasopressin Pathways: Associations with Autism Spectrum Disorders
por: Zhang, Rong, et al.
Publicado: (2017) -
The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review
por: Chojnowski, Karol, et al.
Publicado: (2023) -
Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury
por: Randesi, Matthew, et al.
Publicado: (2017)